|Dr. Hartmut Vennen|
August 23, 2001
|Phone +49 6151 72 2386|
Merck KGaA Appoints Dr. Tilman Schmidt-Lorenz as General Counsel
Darmstadt/Germany, August 23, 2001 - Merck KGaA today announced that Dr. Tilman Schmidt-Lorenz, 48, will succeed, effective December 1, 2001, Prof. Dr. Christian Flaemig, 64, as General Counsel. For a smooth transition, Dr. Schmidt-Lorenz will take up his new position on September 1, 2001. He will report directly to Prof. Dr. Bernhard Scheuble, Merck KGaA´s Chairman and Chief Ecexutive Officer.
Prof. Flaemig, who joined Merck in 1986, will retire on December 1.
Born in Höxter, Germany, Dr. Schmidt-Lorenz studied law and then served, from 1982 until 1994, as an attorney and partner in a Stuttgart based law firm that served corporate clients. In 1994 he joined the holding company of Württembergische Versicherungsgruppe as Head of Corporate Development. Since 1999, he has served in the same position for the new holding company of Wüstenrot & Württembergische AG after the merger of both companies.
Note to editors:
Please download a picture of Dr Schmidt-Lorenz (.jpg, 191k):
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.subscribe.merck.de
to register online, change your selection or discontinue this service. In case of questions, please contact the Media Hotline at: +49 (0)6151 72 5000.
Merck is a global pharmaceutical and chemical company with sales of EUR 5.9 billion in 2004, a history that began in 1668, and a future shaped by 28,900 employees in 52 countries. Its success is characterized by innovations from entrepreneurial employees.
Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds a 73% interest and free shareholders own the remaining 27%. The former U.S. subsidiary, Merck & Co., has been completely independent of the Merck Group since 1917.